Live Quote · NASDAQMLYSHealthcare· Biotechnology

Mineralys Therapeutics, Inc.

$13.66▼ 3.53%($-0.50)
MKT CAP $1.21BNEXT EARNINGS Mar 11, 2027
50%
Bullish
TickerSpark Score
55/100
▌ Mixed
80
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MLYS research report →

Analyst Price Target
$29.00+112.3% vs. today

Range $29 – $29

Analyst RatingBuy
7 Buy1 Hold0 Sell

Price Chart

-67.38% · this period
$43.36$28.51$13.66Nov 20May 26Nov 20
52-Week Range0% of range
Low
$13.57
Current
$13.66
High
$44.13